Severe pyridostigmine toxicity : (Record no. 8083)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 01685nam a22002537a 4500 |
| 001 - CONTROL NUMBER | |
| control field | CH 2010 0007 |
| 003 - CONTROL NUMBER IDENTIFIER | |
| control field | PILC |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20240720152613.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 160505b2010 xxu||||| |||| 00| 0 eng d |
| 040 ## - CATALOGING SOURCE | |
| Language of cataloging | eng |
| Transcribing agency | FEU-NRMF MEDICAL LIBRARY |
| Description conventions | rda |
| 041 ## - LANGUAGE CODE | |
| Language code of text/sound track or separate title | english |
| 050 ## - LIBRARY OF CONGRESS CALL NUMBER | |
| Classification number | CH 2010 0007 |
| 245 ## - TITLE STATEMENT | |
| Title | Severe pyridostigmine toxicity : |
| Remainder of title | a case report / |
| Statement of responsibility, etc. | Joan A. Serrano. |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) | |
| Place of publication, distribution, etc. | Fairview, Quezon City: |
| Name of publisher, distributor, etc. | Department of Child Health, FEU-NRMF, |
| Date of publication, distribution, etc. | 2010. |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 18 pages: |
| Other physical details | illustrations, tables; |
| Dimensions | (in folder) |
| 336 ## - CONTENT TYPE | |
| Content type term | text |
| Source | rdacontent |
| 337 ## - MEDIA TYPE | |
| Media type term | unmediated |
| Source | rdamedia |
| 338 ## - CARRIER TYPE | |
| Carrier type term | volume |
| Source | rdacarrier |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE | |
| Bibliography, etc | Includes appendices and bibliographical references. |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | Abstract: A 13 months old, female diagnosed with congenital myasthenia gravis at 9 months maintained on Pyridostigmine at 15 mg/paper tablet taken 5 times a day with sudden difficulty of breathing, drooling of saliva and seizure. Patient was admitted at the pediatric intensive care unit and inderwent atropinization. Pyridostigmine toxicity in myasthenia gravis is a rare condition since the drug is given to patients based on their signs and symptoms and computed according to their age and weight. Diagnosis can be made based on the presenting clinical signs and symptoms supported by an assay. However, in this case, pyridostigmine assay is available in our country thus, diagnostic dilemma sets in. Such incident warrants investigation and prompt intervention. At present, no standard mode of treatment was established to follow when such case is encountered. |
| 521 ## - TARGET AUDIENCE NOTE | |
| Target audience note | Research - Department of Child Health |
| 700 ## - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Serrano, Joan A., MD. |
| Relator term | author |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) | |
| Source of classification or shelving scheme | Library of Congress Classification |
| Koha item type | Room Use |
| Withdrawn status | Lost status | Source of classification or shelving scheme | Damaged status | Not for loan | Home library | Current library | Shelving location | Date acquired | Total Checkouts | Full call number | Barcode | Date last seen | Price effective from | Koha item type |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Library of Congress Classification | Far Eastern University - Nicanor Reyes Medical Foundation | Far Eastern University - Nicanor Reyes Medical Foundation | Research | 03/05/2015 | CH 2010 0007 | R000048 | 02/29/2016 | 07/22/2016 | Room Use |
